Odyssey Therapeutics, Inc. (ODTX)
19.00
+0.88
(+4.86%)
USD |
NASDAQ |
Oct 09, 16:00
18.92
-0.08
(-0.42%)
After-Hours: 20:00
Odyssey Therapeutics Price to Book Value : 2.160 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.160 |
| October 08, 2026 | 2.060 |
| October 07, 2026 | 2.056 |
| October 06, 2026 | 2.061 |
| October 05, 2026 | 2.369 |
| October 02, 2026 | 2.356 |
| October 01, 2026 | 2.322 |
| September 30, 2026 | 2.526 |
| September 29, 2026 | 2.551 |
| September 28, 2026 | 2.441 |
| September 25, 2026 | 2.332 |
| September 24, 2026 | 2.266 |
| September 23, 2026 | 2.360 |
| September 22, 2026 | 2.654 |
| September 21, 2026 | 2.622 |
| September 18, 2026 | 2.772 |
| September 17, 2026 | 2.64 |
| September 16, 2026 | 2.629 |
| September 15, 2026 | 2.500 |
| September 14, 2026 | 2.758 |
| September 11, 2026 | 2.800 |
| September 10, 2026 | 2.688 |
| September 09, 2026 | 2.787 |
| September 08, 2026 | 3.066 |
| September 04, 2026 | 3.270 |
| Date | Value |
|---|---|
| September 03, 2026 | 3.002 |
| September 02, 2026 | 3.027 |
| September 01, 2026 | 2.786 |
| August 31, 2026 | 2.788 |
| August 28, 2026 | 2.770 |
| August 27, 2026 | 2.954 |
| August 26, 2026 | 2.913 |
| August 25, 2026 | 2.982 |
| August 24, 2026 | 2.860 |
| August 21, 2026 | 3.000 |
| August 20, 2026 | 2.805 |
| August 19, 2026 | 2.757 |
| August 18, 2026 | 2.496 |
| August 17, 2026 | 2.372 |
| August 14, 2026 | 2.357 |
| August 13, 2026 | 2.356 |
| August 12, 2026 | 2.454 |
| August 11, 2026 | 2.314 |
| August 10, 2026 | 2.521 |
| August 07, 2026 | 2.407 |
| August 06, 2026 | 2.450 |
| August 05, 2026 | 2.375 |
| August 04, 2026 | 2.269 |
| August 03, 2026 | 2.061 |
| July 31, 2026 | 2.152 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.98 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.034 |
| Vericel Corp. | 5.545 |
Price to Book Value Related Metrics
| PS Ratio | 316.97 |
| PEG Ratio | -0.0389 |
| Price | 19.00 |
| Earnings Yield | -18.72% |
| Market Cap | 909.93M |
| PEGY Ratio | -0.0389 |